Skip to main content

Table 1 Clinical and pathological characteristics of patients with advanced epithelial ovarian cancer undergoing peritonectomy with or without HIPEC

From: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years’ experience

Variable

n = 41

Range

Age (median, years)

55.0

33–73

Follow-up (median, months)

46.0

 

Length of stay (days)

 ICU

4.5

1–32

 Hospital

29.3

7–82

Operating time (mean, h)

8.2

4–14

Variable

n = 41

n (%)

Presentation

 Primary

11

27

 Recurrent

30

73

Tumour origin

 Ovarian

33

80

 Fallopian tube

4

10

 Peritoneal

4

10

Histology

 High grade serous

32

78

 Endometrioid

0

0

 Mucinous

3

7

 Clear cell

1

2

 Low grade serous

5

12

Peritoneal Cancer Index (PCI)

 ≤ 15

13

32

 > 15

28

68

Completeness of cytoreduction (CC score)

 0

24

59

 1

16

39

 2

1

2

 3

0

0

HIPEC

 Yes

29

71

 No

12

29

Complications (Clavien-Dindo)

 None

9

22

 Grade 1/2

17

41

 Grade 3/4

14

34

 Death

1

2